Dr. Weingarden received his Doctorate in Medicine from The University of Michigan School of Medicine. He completed his Internship and Residency in Internal Medicine at University of Texas Southwestern Medical Center and Parkland Memorial Hospital in Dallas. He completed his Fellowship in Cardiology at Baylor University Medical Center in Dallas. Dr. Weingarden is Board Certified in Internal Medicine and Cardiovascular Disease.
Dr. Bellomo attended the University of Califonia, where he received his undergraduate degree.
Shelley A. Hall, M.D., is the Director of Heart Transplant Services for HeartPlace.
Dr. Lander specializes in Interventional Cardiology and Cardiovascular Disease.
Dr. Raza specializes in Cardiovascular Disease and Cardiovascular Imaging.
HeartPlace is the past, present, and future of cardiology in North Texas. Founded almost 50 years ago, HeartPlace is the oldest and largest cardiovascular group in North Texas. From its small beginning in Dallas, HeartPlace has grown to over 70 physicians throughout the Dallas-Fort Worth metroplex. HeartPlace has been an innovator in cardiovascular services, introducing to the North Texas area procedures such as coronary angiography, angioplasty, coronary stenting, and electrophysiology. This dedication to innovative techniques and procedures has guaranteed our patients the latest and most up-to-date cardiovascular services...
Selective serotonin reuptake inhibitors (SSRIs) don't appear to raise cardiovascular risk among young and middle-age patients, according to research published online March 22 in The BMJ.Read More
Laser ablation for varicose veins is an effective and minimally invasive technique for the treatment of varicose. However, this kind of therapy is associated with significant collateral damage because of the high output power of the laser. Therefore, it is an important issue in vein surgery to optimize the laser characteristics for ablation.
In a trial of more than 27,000 patients, researchers found that taking monthly or twice-monthly injections of the medication, called evolocumab, on top of statins could cut cholesterol levels by almost 60 per cent on average in patients with an underlying risk of cardiovascular disease.
Source: Medical Xpress Read More
A large international study has shown conclusively that statin treatment reduces the risk of cardiovascular disease in women. The research confirms that statins are beneficial not only to women who have already had a cardiovascular event such as a heart attack or stroke, but also in those who - whilst they have not yet developed cardiovascular disease -- are at an increased risk of such diseases. Source: Science Daily Read More Read More
Morning home blood pressure (HBP) is a robust predictor of stroke and coronary artery disease (CAD) events, according to research published in the April 5 issue of the Journal of the American College of Cardiology.Read More